IL2RA and myeloid sarcoma: Our findings indicate that CD25 heterogeneity within CD4+ T cell subgroups are dependent on MS-associated IL2RA gene variants and emphasizes that cell subsets need to be clearly defined by several markers in studies of MS-associated IL2RA gene variants.